Idiopathic Multicentric Castleman Disease
📧 Sign up to get email alerts when something new happens for Idiopathic Multicentric Castleman Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Ruxolitinib in Previously Treated Idiopathic Multicentric Castleman Disease [Phase 2]
Phase 2 clinical trial evaluating ruxolitinib in previously treated idiopathic multicentric Castleman disease; recruitment ongoing.
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: A Study of Anti-IL-6R mAb Injection in Patients With iMCD [Phase 2]
A Phase 2 study evaluating an anti-IL-6 receptor monoclonal antibody in idiopathic multicentric Castleman's disease is currently active but …